Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-113.20M
↓ 127% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-49.92M
Historical baseline
PeriodValueYoY Change
2025$-113.20M-60.0%
2024$-70.76M-111.5%
2023$-33.46M-21.4%
2022$-27.57M+34.5%
2021$-42.10M+0.2%
2020$-42.20M-85.9%
2019$-22.70M+55.9%
2018$-51.49M-17.6%
2017$-43.78M+15.8%
2016$-51.98M-